JME Ventures launches venture capital fund focused on health and longevity

2026-11-16T10:40:00
Spain

Cuatrecasas advises JME Ventures on formation of venture capital fund JME Longevity I, focused on health and longevity

JME Ventures launches venture capital fund focused on health and longevity
November 16, 2026

Cuatrecasas has advised JME Venture Capital SGEIC on the formation of JME Longevity I, a new venture capital fund. The fund will invest in companies whose products and services help improve quality of life and life expectancy. Its investment scope covers entities and businesses in life sciences, healthcare biotechnology, medical technology, digital health, healthcare services, pharmaceuticals, and medical devices. It also encompasses wellbeing, prevention, diagnosis, treatment, and care services.

Having launched four venture capital funds, the fund manager is now focusing on longevity. This field differs from its previous tech investments and calls for a dedicated strategy and fund.

JME Longevity I will focus on three areas: diagnosis and prevention, therapies, and platforms that will develop better therapies. Investments could be allocated approximately as follows: European Union (70%), United States (20%), and Asia (10%).

The Cuatrecasas advisory team comprised lawyers Jorge Canta, Paz Irazusta, and Juan Manuel Navajas, from the Fund Formation Group.

November 16, 2026